Malignant Neoplasm Clinical Trials in New York, New York

4 studies are recruiting for malignant neoplasm in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with hepatoblastoma or rhabdomyosarcoma (RMS) that has relapsed or is refractory: * Hepatoblastoma is a common liver cancer in babies and very young children * RMS is a cancer that starts in muscle cells, often in a child's head and neck, bladd…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   Memorial Sloan Kettering Cancer Center ( Site 3010), New York, New York

   Locations

   63 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06941272 on ClinicalTrials.gov

2. A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (get smaller or go away) to treatment * Solid tumors are cancers mostly in body organs and tissues, no…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   Memorial Sloan Kettering Cancer Center ( Site 4010), New York, New York

   Locations

   26 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07630974 on ClinicalTrials.gov

3. A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

   Researchers want to learn if MK-5684 (the study medicine) can treat breast cancer, ovarian cancer, and endometrial cancer. MK-5684, the study medicine, is designed to treat cancer by blocking the body from making steroid hormones. Researchers will compare MK-5684 to the standard treatments for each…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Rockefeller Outpatient Pavilion ( Site 0002), New York, New York

   Locations

   59 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06979596 on ClinicalTrials.gov

4. Project: Every Child for Younger Patients With Cancer

   This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

   Stage

   Not phased

   Ages

   Up to 25

   Site

   Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

   Locations

   279 in total

   Run by

   Children's Oncology Group

   See if you can join NCT02402244 on ClinicalTrials.gov